Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis

Frontiers in Microbiology

Volumn 2, Issue FEB, 2011, Pages

  Gall, Alevtina ^a   Horowitz, Amir ^b   Joof, Hassan ^a   Natividad, Angels ^b   Tetteh, Kevin ^b   Riley, Eleanor ^b   Bailey, Robin L ^b   Mabey, David C W ^b   Holland, Martin J ^a,b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Chlamydia trachomatis; Immune response; Interferon gamma; NK cells; Trachoma; Tregs

Indexed keywords

EID: 82155184199     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00010     Document Type: Article

References (75)

1. Anderson, C. F., Oukka, M., Kuchroo, V. J., and Sacks, D. (2007). CD4(+)CD25(-) Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285-297.
2. Bailey, R., Duong, T., Carpenter, R., Whittle, H., and Mabey, D. (1999). The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol. Infect. 123, 479-486.
3. Bailey, R. L., Holland, M. J., Whittle, H. C., and Mabey, D. C. (1995). Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect. Immun. 63, 389-392.
4. Barker, C. J., Beagley, K. W., Hafner, L. M., and Timms, P. (2008). In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Vaccine 26, 1285-1296.
5. Belkaid, Y., and Tarbell, K. (2009). Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 27, 551-589.
6. Bennett, S., and Riley, E. M. (1992). The statistical analysis of data from immunoepidemiological studies. J. Immunol. Methods 146, 229-239.
7. Burl, S., Adetifa, U. J., Cox, M., Touray, E., Ota, M. O., Marchant, A., Whittle, H., McShane, H., Rowland-Jones, S. L., and Flanagan, K. L. (2010). Delaying bacillus Calmette-Guerin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J. Immunol. 185, 2620-2628.
8. Burton, M. J., Adegbola, R. A., Kinteh, F., Ikumapayi, U. N., Foster, A., Mabey, D. C., and Bailey, R. L. (2007). Bacterial infection and trachoma in the Gambia: a case control study. Invest. Ophthalmol. Vis. Sci. 48, 4440-4444.
9. Burton, M. J., Bailey, R. L., Jeffries, D., Mabey, D. C., and Holland, M. J. (2004). Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect. Immun. 72, 7352-7356.
10. Burton, M. J., Bailey, R. L., Jeffries, D., Rajak, S. N., Adegbola, R. A., Sillah, A., Mabey, D. C., and Holland, M. J. (2010). Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. Invest. Ophthalmol. Vis. Sci. 51, 3583-3590.
11. Burton, M. J., Rajak, S. N., Bauer, J., Weiss, H. A., Tolbert, S. B., Shoo, A., Habtamu, E., Manjurano, A., Emerson, P. M., Mabey, D. C., Holland, M. J., and Bailey, R. L. (2011). The conjunctival transcriptome in scarring trachoma. Infect. Immun. 79, 499-511.
12. Chiaramonte, M. G., Mentink-Kane, M., Jacobson, B. A., Cheever, A. W., Whitters, M. J., Goad, M. E., Wong, A., Collins, M., Donaldson, D. D., Grusby, M. J., and Wynn, T. A. (2003). Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197, 687-701.
13. Cohen, C. R., Koochesfahani, K. M., Meier, A. S., Shen, C., Karunakaran, K., Ondondo, B., Kinyari, T., Mugo, N. R., Nguti, R., and Brunham, R. C. (2005). Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma. J. Infect. Dis. 192, 591-599.
14. Coler, R. N., Bhatia, A., Maisonneuve, J. F., Probst, P., Barth, B., Ovendale, P., Fang, H., Alderson, M., Lobet, Y., Cohen, J., Mettens, P., and Reed, S. G. (2009). Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis. FEMS Immunol. Med. Microbiol. 55, 258-270.
15. Cotter, T. W., Meng, Q., Shen, Z. L., Zhang, Y. X., Su, H., and Caldwell, H. D. (1995). Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63, 4704-4714.
16. Crane, D. D., Carlson, J. H., Fischer, E. R., Bavoil, P., Hsia, R. C., Tan, C., Kuo, C. C., and Caldwell, H. D. (2006). Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc. Natl. Acad. Sci. U.S.A. 103, 1894-1899.
17. Faal, N., Bailey, R. L., Jeffries, D., Joof, H., Sarr, I., Laye, M., Mabey, D. C., and Holland, M. J. (2006). Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? PLoS Med. 3, e266. doi: 10.1371/ journal.pmed.0030266
18. Felton, M. (2002). Studies of Human Immune Responses to Various Antigenic Proteins of Chlamydia trachomatis. Ph. D. thesis, University of London (LSHTM), London.
19. Finney, O. C., Riley, E. M., and Walther, M. (2010). Phenotypic analysis of human peripheral blood regulatory T cells (CD4+FOXP3+CD127lo/-) ex vivo and after in vitro restimulation with malaria antigens. Eur. J. Immunol. 40, 47-60.
20. Follmann, F., Olsen, A. W., Jensen, K. T., Hansen, P. R., Andersen, P., and Theisen, M. (2008). Antigenic profiling of a Chlamydia trachomatis gene-expression library. J. Infect. Dis. 197, 897-905.
21. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005). Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341.
22. Gervassi, A. L., Grabstein, K. H., Probst, P., Hess, B., Alderson, M. R., and Fling, S. P. (2004). Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis. J. Immunol. 173, 6905-6913.
23. Gondek, D. C., Roan, N. R., and Starnbach, M. N. (2009). T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis. J. Immunol. 183, 1313-1319.
24. Goodall, J. C., Beacock-Sharp, H., Deane, K. H., and Gaston, J. S. (2001a). Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis. Clin. Exp. Immunol. 126, 488-493.
25. Goodall, J. C., Yeo, G., Huang, M., Raggiaschi, R., and Gaston, J. S. (2001b). Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library. Eur. J. Immunol. 31, 1513-1522.
26. Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., and Ley, T. J. (2004). Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601.
27. Harding-Esch, E. M., Edwards, T., Sillah, A., Sarr, I., Roberts, C. H., Snell, P., Aryee, E., Molina, S., Holland, M. J., Mabey, D. C. W., and Bailey, R. L. (2009a). Active trachoma and ocular Chlamydia trachomatis infection in the Gambia: on course for elimination by 2020? PLoS Negl. Trop. Dis. 3, e573. doi: 10.1371/journal.pntd.0000573
28. Holland, M. J., Bailey, R. L., Conway, D. J., Culley, F., Miranpuri, G., Byrne, G. I., Whittle, H. C., and Mabey, D. C. (1996). T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin. Exp. Immunol. 105, 429-435.
29. Holland, M. J., Bailey, R. L., Hayes, L. J., Whittle, H. C., and Mabey, D. C. (1993). Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J. Infect. Dis. 168, 1528-1531.
30. Holland, M. J., Jeffries, D., Pattison, M., Korr, G., Gall, A., Joof, H., Manjang, A., Burton, M. J., Mabey, D. C., and Bailey, R. L. (2010). Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis. Invest. Ophthalmol. Vis. Sci. 51, 3893-3902.
31. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
32. Horowitz, A., Behrens, R. H., Okell, L., Fooks, A. R., and Riley, E. M. (2010a). NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J. Immunol. 185, 2808-2818.
33. Horowitz, A., Newman, K. C., Evans, J. H., Korbel, D. S., Davis, D. M., and Riley, E. M. (2010b). Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 184, 6043-6052.
34. Horowitz, A., and Riley, E. M. (2010). Activation of human NK cells by malaria-infected red blood cells. Methods Mol. Biol. 612, 429-446.
35. Igietseme, J. U., He, Q., Joseph, K., Eko, F. O., Lyn, D., Ananaba, G., Campbell, A., Bandea, C., and Black, C. M. (2009). Role of T lymphocytes in the pathogenesis of Chlamydia disease. J. Infect. Dis. 200, 926-934.
36. Jankovic, D., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M., Wynn, T. A., Kamanaka, M., Flavell, R. A., and Sher, A. (2007). Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283.
37. Jiang, H., and Chess, L. (2004). An integrated view of suppressor T cell subsets in immunoregulation. J. Clin. Invest. 114, 1198-1208.
38. Kari, L., Whitmire, W. M., Crane, D. D., Reveneau, N., Carlson, J. H., Goheen, M. M., Peterson, E. M., Pal, S., de la Maza, L. M., and Caldwell, H. D. (2009). Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J. Immunol. 182, 8063-8070.
39. Kelly-Rogers, J., Madrigal-Estebas, L., O'Connor, T., and Doherty, D. G. (2006). Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. Hum. Immunol. 67, 863-873.
40. Kim, S. K., and DeMars, R. (2001). Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Curr. Opin. Immunol. 13, 429-436.
41. Knight, S. C., Iqball, S., Woods, C., Stagg, A., Ward, M. E., and Tuffrey, M. (1995). Chlamydia trachomatis A peptide of shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo. Immunology 85, 8-15.
42. Li, W., Janowicz, D. M., Fortney, K. R., Katz, B. P., and Spinola, S. M. (2009). Mechanism of human natural killer cell activation by Haemophilus ducreyi. J. Infect. Dis. 200, 590-598.
43. Linn, Y. C., Lau, S. K., Liu, B. H., Ng, L. H., Yong, H. X., and Hui, K. M. (2009). Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell. Immunology 126, 423-435.
44. Mabey, D. C., Solomon, A. W., and Foster, A. (2003). Trachoma. Lancet 362, 223-229.
45. Maloy, K. J., and Powrie, F. (2001). Regulatory T cells in the control of immune pathology. Nat. Immunol. 2, 816-822.
46. Mariotti, S. P., Pascolini, D., and Rose-Nussbaumer, J. (2009). Trachoma: global magnitude of a preventable cause of blindness. Br. J. Ophthalmol. 93, 563-568.
47. McCall, M. B., Roestenberg, M., Ploemen, I., Teirlinck, A., Hopman, J., de Mast, Q., Dolo, A., Doumbo, O. K., Luty, A., van der Ven, A. J., Hermsen, C. C., and Sauerwein, R. W. (2010). Memory-like IFN-gamma response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur. J. Immunol. 40, 3472-3477.
48. McGuirk, P., McCann, C., and Mills, K. H. (2002). Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221-231.
49. Meier, U. C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K., Newton, P., Pellegrino, P., Williams, I., Klenerman, P., and Borrow, P. (2005). Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 79, 12365-12374.
50. Natividad, A., Freeman, T. C., Jeffries, D., Burton, M. J., Mabey, D. C., Bailey, R. L., and Holland, M. J. (2010). Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. Infect. Immun. 78, 4895-4911.
51. Natividad, A., Holland, M. J., Rockett, K. A., Forton, J., Faal, N., Joof, H. M., Mabey, D. C., Bailey, R. L., and Kwiatkowski, D. P. (2008). Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum. Mol. Genet. 17, 323-329.
52. Natividad, A., Wilson, J., Koch, O., Holland, M. J., Rockett, K., Faal, N., Jallow, O., Joof, H. M., Burton, M. J., Alexander, N. D., Kwiatkowski, D. P., Mabey, D. C., and Bailey, R. L. (2005). Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun. 6, 332-340.
53. Nesburn, A. B., Bettahi, I., Dasgupta, G., Chentoufi, A. A., Zhang, X., You, S., Morishige, N., Wahlert, A. J., Brown, D. J., Jester, J. V., Wechsler, S. L., and BenMohamed, L. (2007). Functional Foxp3+ CD4+ CD25(bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. J. Virol. 81, 7647-7661.
54. Nocentini, G., and Riccardi, C. (2005). GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 35, 1016-1022.
55. Nunes, A., Nogueira, P. J., Borrego, M. J., and Gomes, J. P. (2010). Adaptive evolution of the Chlamydia trachomatis dominant antigen reveals distinct evolutionary scenarios for B-and T-cell epitopes: worldwide survey. PLoS ONE 5, e13171. doi: 10.1371/journal. pone.0013171
56. Olsen, A. W., Follmann, F., Hojrup, P., Leah, R., Sand, C., Andersen, P., and Theisen, M. (2007). Identification of human T cell targets recognized during Chlamydia trachomatis genital infection. J. Infect. Dis. 196, 1546-1552.
57. Olsen, A. W., Follmann, F., Jensen, K., Hojrup, P., Leah, R., Sorensen, H., Hoffmann, S., Andersen, P., and Theisen, M. (2006). Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection. J. Infect. Dis. 194, 1258-1266.
58. Olsen, A. W., Theisen, M., Christensen, D., Follmann, F., and Andersen, P. (2010). Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model. PLoS ONE 5, e10768. doi: 10.1371/journal.pone.0010768
59. Rockey, D. D., Wang, J., Lei, L., and Zhong, G. (2009). Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev. Vaccines 8, 1365-1377.
60. Skwor, T., Kandel, R. P., Basravi, S., Khan, A., Sharma, B., and Dean, D. (2010). Characterization of humoral immune responses to chlamydial heat shock protein 60, protease-like activity factor and hypothetical protein CT795 in inflammatory and severe trachoma. Invest. Ophthalmol. Vis. Sci. 51, 5128-5136.
61. Stock, P., Akbari, O., Berry, G., Freeman, G. J., Dekruyff, R. H., and Umetsu, D. T. (2004). Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5, 1149-1156.
62. Suvas, S., Azkur, A. K., Kim, B. S., Kumaraguru, U., and Rouse, B. T. (2004). CD4(+)CD25(+) regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172, 4123-4132.
63. Thorpe, C., Edwards, L., Snelgrove, R., Finco, O., Rae, A., Grandi, G., Guilio, R., and Hussell, T. (2007). Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection. Vaccine 25, 2252-2260.
64. Titanji, K., Sammicheli, S., De Milito, A., Mantegani, P., Fortis, C., Berg, L., Kärre, K., Travi, G., Tassandin, C., Lopalco, L., Rethi, B., Tambussi, G., and Chiodi, F. (2008). Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection. Immunology 123, 164-170.
65. Vieira, P. L., Christensen, J. R., Minaee, S., ONeill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T., Stockinger, B., Wraith, D. C., and O'Garra, A. (2004). IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172, 5986-5993.
66. Wang, C., Tang, J., Geisler, W. M., Crowley-Nowick, P. A., Wilson, C. M., and Kaslow, R. A. (2005). Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J. Infect. Dis. 191, 1084-1092.
67. Wang, J., Chen, L., Chen, F., Zhang, X., Zhang, Y., Baseman, J., Perdue, S., Yeh, I. T., Shain, R., Holland, M., Bailey, R., Mabey, D., Yu, P., and Zhong, G. (2009). A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine 27, 2967-2980.
68. Wang, J., Zhang, Y., Lu, C., Lei, L., Yu, P., and Zhong, G. (2010). A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J. Immunol. 185, 1670-1680.
69. Wang, S., Fan, Y., Brunham, R. C., and Yang, X. (1999). IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur. J. Immunol. 29, 3782-3792.
70. WHO. (2007). Sexually Transmitted Diseases: Chlamydia trachomatis. Geneva: WHO.
71. Wynn, T. A. (2004). Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4, 583-594.
72. Yang, X. (2003). Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr. Pharm. Des. 9, 67-73.
73. Yang, X., Gartner, J., Zhu, L., Wang, S., and Brunham, R. C. (1999). IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162, 1010-1017.
74. Zhang, D., Yang, X., Berry, J., Shen, C., McClarty, G., and Brunham, R. C. (1997). DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J. Infect. Dis. 176, 1035-1040.
75. Zheng, X., Gao, J. X., Chang, X., Wang, Y., Liu, Y., Wen, J., Zhang, H., Zhang, J., and Zheng, P. (2004). B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8-T cells in the thymus. J. Immunol. 173, 2253-2261